Publications by authors named "Bridgette Hockenjos"
Gastroenterology
March 2006
Article Synopsis
- The study tested the effectiveness and safety of pegylated interferon alfa-2b for treating acute hepatitis C virus infections, as previous evaluations were lacking.
- A total of 175 patients were enrolled, with 129 starting treatment at different weeks (8, 12, or 20), and the main goal was to achieve undetectable HCV RNA 24 weeks after treatment.
- The results showed an overall sustained virologic response (SVR) rate of 87%, with higher success rates for earlier treatment initiation, particularly beneficial for certain genotypes of the virus.
